Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of the Effect of Continuous Glucose Monitoring (CGM) in Individuals With Newly Diagnosed Type 2 Diabetes

NCT06471699 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06471699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06471699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of the Effect of Continuous Glucose Monitoring (CGM) in Individuals With Newly Diagnosed Type 2 Diabetes
Lead sponsor
Vastra Gotaland Region
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2024
Completion date
December 31, 2030
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2